Literature DB >> 21471095

Viral infection in acute exacerbation of idiopathic pulmonary fibrosis.

Sharon Chao Wootton1, Dong Soon Kim, Yasuhiro Kondoh, Eunice Chen, Joyce S Lee, Jin Woo Song, Jin Won Huh, Hiroyuki Taniguchi, Charles Chiu, Homer Boushey, Lisa H Lancaster, Paul J Wolters, Joseph DeRisi, Don Ganem, Harold R Collard.   

Abstract

RATIONALE: Idiopathic pulmonary fibrosis is a progressive, uniformly fatal interstitial lung disease. An acute exacerbation of idiopathic pulmonary fibrosis is an episode of acute respiratory worsening without an identifiable etiology. Occult viral infection has been proposed as a possible cause of acute exacerbation.
OBJECTIVES: To use unbiased genomics-based discovery methods to define the role of viruses in acute exacerbation of idiopathic pulmonary fibrosis.
METHODS: Bronchoalveolar lavage and serum from patients with acute exacerbation of idiopathic pulmonary fibrosis, stable disease, and acute lung injury were tested for viral nucleic acid using multiplex polymerase chain reaction, pan-viral microarray, and high-throughput cDNA sequencing.
MEASUREMENTS AND MAIN RESULTS: Four of forty-three patients with acute exacerbation of idiopathic pulmonary fibrosis had evidence of common respiratory viral infection (parainfluenza [n = 1], rhinovirus [n = 2], coronavirus [n = 1]); no viruses were detected in the bronchoalveolar lavage from stable patients. Pan-viral microarrays revealed additional evidence of viral infection (herpes simplex virus [n = 1], Epstein-Barr virus [n = 2], and torque teno virus [TTV] [n = 12]) in patients with acute exacerbation. TTV infection was significantly more common in patients with acute exacerbation than stable controls (P = 0.0003), but present in a similar percentage of acute lung injury controls. Deep sequencing of a subset of acute exacerbation cases confirmed the presence of TTV but did not identify additional viruses.
CONCLUSIONS: Viral infection was not detected in most cases of acute exacerbation of idiopathic pulmonary fibrosis. TTV was present in a significant minority of cases, and cases of acute lung injury; the clinical significance of this finding remains to be determined.

Entities:  

Mesh:

Year:  2011        PMID: 21471095      PMCID: PMC3136996          DOI: 10.1164/rccm.201010-1752OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  32 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Microarray-based detection and genotyping of viral pathogens.

Authors:  David Wang; Laurent Coscoy; Maxine Zylberberg; Pedro C Avila; Homer A Boushey; Don Ganem; Joseph L DeRisi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

3.  Pirfenidone in idiopathic pulmonary fibrosis.

Authors:  H Taniguchi; M Ebina; Y Kondoh; T Ogura; A Azuma; M Suga; Y Taguchi; H Takahashi; K Nakata; A Sato; M Takeuchi; G Raghu; S Kudoh; T Nukiwa
Journal:  Eur Respir J       Date:  2009-12-08       Impact factor: 16.671

4.  Detection of a novel DNA virus (TTV) sequence in peripheral blood mononuclear cells.

Authors:  A Okamura; M Yoshioka; M Kubota; H Kikuta; H Ishiko; K Kobayashi
Journal:  J Med Virol       Date:  1999-06       Impact factor: 2.327

5.  Anticoagulant therapy for idiopathic pulmonary fibrosis.

Authors:  Hiroshi Kubo; Katsutoshi Nakayama; Masaru Yanai; Tomoko Suzuki; Mutsuo Yamaya; Mika Watanabe; Hidetada Sasaki
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

6.  Metagenomic analysis of the human distal gut microbiome.

Authors:  Steven R Gill; Mihai Pop; Robert T Deboy; Paul B Eckburg; Peter J Turnbaugh; Buck S Samuel; Jeffrey I Gordon; David A Relman; Claire M Fraser-Liggett; Karen E Nelson
Journal:  Science       Date:  2006-06-02       Impact factor: 47.728

7.  Infection of TT virus in patients with idiopathic pulmonary fibrosis.

Authors:  M Bando; S Ohno; K Oshikawa; M Takahashi; H Okamoto; Y Sugiyama
Journal:  Respir Med       Date:  2001-12       Impact factor: 3.415

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  TT virus replicates in stimulated but not in nonstimulated peripheral blood mononuclear cells.

Authors:  Luisa F Mariscal; Juan Manuel López-Alcorocho; Elena Rodríguez-Iñigo; Nuria Ortiz-Movilla; Susana de Lucas; Javier Bartolomé; Vicente Carreño
Journal:  Virology       Date:  2002-09-15       Impact factor: 3.616

10.  E-Predict: a computational strategy for species identification based on observed DNA microarray hybridization patterns.

Authors:  Anatoly Urisman; Kael F Fischer; Charles Y Chiu; Amy L Kistler; Shoshannah Beck; David Wang; Joseph L DeRisi
Journal:  Genome Biol       Date:  2005-08-30       Impact factor: 13.583

View more
  87 in total

Review 1.  Update in respiratory infections 2011.

Authors:  Richard G Wunderink; Michael S Niederman
Journal:  Am J Respir Crit Care Med       Date:  2012-06-15       Impact factor: 21.405

Review 2.  Update in diffuse parenchymal lung disease 2011.

Authors:  Tracy R Luckhardt; Joachim Müller-Quernheim; Victor J Thannickal
Journal:  Am J Respir Crit Care Med       Date:  2012-07-01       Impact factor: 21.405

3.  Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure.

Authors:  Kerri A Johannson; Eric Vittinghoff; Kiyoung Lee; John R Balmes; Wonjun Ji; Gilaad G Kaplan; Dong Soon Kim; Harold R Collard
Journal:  Eur Respir J       Date:  2013-10-31       Impact factor: 16.671

4.  Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.

Authors:  MeiLan K Han; Yueren Zhou; Susan Murray; Nabihah Tayob; Imre Noth; Vibha N Lama; Bethany B Moore; Eric S White; Kevin R Flaherty; Gary B Huffnagle; Fernando J Martinez
Journal:  Lancet Respir Med       Date:  2014-04-21       Impact factor: 30.700

5.  Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis.

Authors:  L Ten Klooster; C H M van Moorsel; J M Kwakkel-van Erp; H van Velzen-Blad; J C Grutters
Journal:  Clin Exp Immunol       Date:  2015-06-08       Impact factor: 4.330

6.  A first glimpse at the early origins of idiopathic pulmonary fibrosis.

Authors:  Oliver Eickelberg; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

7.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.

Authors:  Kerri Johannson; Harold R Collard
Journal:  Curr Respir Care Rep       Date:  2013-12

8.  Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies.

Authors:  Sachiko Seo; Christian Renaud; Jane M Kuypers; Charles Y Chiu; Meei-Li Huang; Erik Samayoa; Hu Xie; Guixia Yu; Cynthia E Fisher; Ted A Gooley; Steven Miller; Robert C Hackman; David Myerson; Ruth H Sedlak; Yae-Jean Kim; Takahiro Fukuda; David N Fredricks; David K Madtes; Keith R Jerome; Michael Boeckh
Journal:  Blood       Date:  2015-04-27       Impact factor: 22.113

9.  Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease.

Authors:  Hideyuki Niwa; Yoshiro Nakahara; Masanori Yokoba; Hisashi Mitsufuji; Jiichiro Sasaki; Noriyuki Masuda
Journal:  Mol Clin Oncol       Date:  2017-08-03

Review 10.  Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation.

Authors:  Bethany B Moore; Thomas A Moore
Journal:  Ann Am Thorac Soc       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.